A cross-sectional study of homocysteine-, NO-levels, and CT-findings in Alzheimer dementia, vascular dementia and controls

Biogerontology

Volumn 6, Issue 4, 2005, Pages 255-260

  Folin, Marcella ^a   Baiguera, Silvia ^a   Gallucci, Maurizio ^b   Conconi, Maria Teresa ^a   Di Liddo, Rosa ^a   Zanardo, Andrea ^b   Parnigotto, Pier Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CA FONCELLO HOSPITAL   (Italy)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cognitive impairment; Homocysteine; Neuroimaging; Nitric oxide; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E; HOMOCYSTEINE; NITRIC OXIDE;

AGED; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BRAIN ATROPHY; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HOMOCYSTEINE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PHENOTYPE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEMENTIA, VASCULAR; HOMOCYSTEINE; HUMANS; NITRIC OXIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 31044450458     PISSN: 13895729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10522-005-2622-3     Document Type: Article

References (32)

1. Adiloglu AK, Gurakur-Osborne A and Prete PE (1998) Standardized determination of apolipoprotein E phenotypes by simplified focusing/ immunoblotting in plasma and synovial fluid. Clin Chim Acta 273: 99-102 9620475 1:CAS:528:DyaK1cXjsFKju7k%3D
2. Benthin G, Bjorkhem I, Breuer O, Sakinis A and Wennmalm A (1997) Transformation of subcutaneous nitric oxide into nitrite and nitrate in rat. Biochem J 323: 853-858 9169622 1:CAS:528:DyaK2sXjtFKjur8%3D
3. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55: 1449-1455 10.1001/ archneur.55.11.1449 9823829 1:STN:280:DyaK1M%2FjvFCgtw%3D%3D
4. Consensus Report of Working Group on: 'Molecular and biochemical markers of Alzheimer's disease' (1998) Neurobiology of Aging 19: 109-116
5. Corder EH, Saunders AM, Strittmatter WJ, Haines J, Pericak-Vance MS and Roses AD (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923 8346443 1:CAS:528:DyaK3sXmtVWjur8%3D
6. Cuenod CA, Denys A, Michot JL, Jehenson P, Forette F, Kaplan D, Syrota A and Boller F (1993) Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol 50: 941-945 8363448 1:STN:280:ByyA2s7itVI%3D
7. Dawson VL and Dawson TM (1996) Nitric oxide in neuronal degeneration. Proc Soc Exp Biol Med 211: 33-40 8594616 1:CAS:528:DyaK28XlslejtQ%3D%3D
8. Dawson VL and Dawson TM (1998) Nitric oxid in neurodegeneration, Prog Brain Res 118: 215-229 9932444 1:CAS:528:DyaK1cXnvFynsbY%3D
9. Folin M, Baiguera S, Conconi MT, Di Liddo R, De Carlo E, Parnigotto PP and Nussdorfer GG (2004) Apolipoprotein E as vascular risk factor in neurodegenerative dementia. Int J Mol Med 14: 609-613 15375590 1:CAS:528:DC%2BD2cXovFWntL0%3D
10. Folstein MF, Folstein SE and McHugh PR (1975) Mini-Mental State - A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198 10.1016/0022-3956(75)90026-6 1202204 1:STN:280:CSmD2s7mtVE%3D
11. Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC and Rossor MN (2001) Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358: 201-205 10.1016/S0140-6736(01)05408-3 11476837 1:STN:280:DC%2BD3MvivV2itA%3D%3D
12. Iqbal K (1991) Prevalence and neurobiology of Alzheimer disease: Some highlights. In: Iqbal K, McLachlan DRC, Winblad B and Wisnieski HM (eds) Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutics Strategies, pp 9-12. Wiley Intersciences, Chichester
13. Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Tangalos EG and Kokmen E (2000) Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55: 484-489 10953178
14. Joosten E, Lesaffre E, Riezler R, Ghekiere V, Dereymaeker L, Pelemans W and Dejaeger E (1997) Is metabolic evidence for vitamin B 12 and folate deficiency more frequent in elderly patients with Alzheimer's disease?. J Gerontol A Biol Sci Med 52: M76-M79 1:STN:280:ByiB3MvlvFc%3D
15. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L and Mattson MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20: 6920-6926 10995836 1:CAS:528:DC%2BD3cXmvVGhs78%3D
16. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M and Mattson MP (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22: 1752-1762 11880504 1:CAS:528:DC%2BD38XhvValtbw%3D
17. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, Arnelle DR and Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl- d -aspartate receptor. Proc Natl Acad Sci USA 94: 5923-5928 10.1073/pnas.94.11.5923 9159176 1:CAS:528:DyaK2sXjsFOks7g%3D
18. Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Crain B, Tang MX and Phelps CH (1998) Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N Engl J Med 338: 10.1056/NEJM199802193380804 9468467 1:STN:280:DyaK1c7islCltA%3D%3D
19. McCaddon A, Davies G, Hudson P, Tandy S and Cattel H (1998) Total serum homocysteine in senile dementia of Alzheimer type. Int J Ger Psych 13: 235-239 1:STN:280:DyaK1czhtVWiug%3D%3D
20. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore CP (2002) Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 33: 2351-2356 10.1161/ 01.STR.0000032550.90046.38 12364720 1:CAS:528:DC%2BD38Xntlamsr4%3D
21. Moshage H, Kok B, Huizenge JR and Jansen PLM (1995) Nitrite and nitrate determination in plasma: A critical evaluation. Clin Chem 41: 892 7768008 1:CAS:528:DyaK2MXmtV2mtbk%3D
22. Moshage H (1997) Nitric oxide determinations: Much ado about NO-things?. Clin Chem 43: 553 9105253 1:CAS:528:DyaK2sXitlymsLY%3D
23. Religa D, Styczynska M, Peplonska B, Gabryelewicz T, Pfeffer A, Chodakowska M, Luczywek E, Wasiak B, Stepien K, Golebiowski M, Winblad B and Barcikowska M (2003) Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 16(2), 64-70 10.1159/ 000070677 12784029 1:CAS:528:DC%2BD3sXkt12qtr0%3D
24. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JL, Garcia JH Amaducci L, Orgogozo JM, Brun A and Hofman A (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-ARIEN International workshop. Neurology 43: 250-260 8094895 1:STN:280:ByyC2szivFc%3D
25. Roman GC (2001) Diagnosis of vascular dementia and Alzheimer's disease. Int J Clin Pract Suppl 120: 9-13 11406927
26. Salter M, Duffy C, Garthwaite J and Strijbos JP (1996) Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J Neurochem 66: 1683-1690 8627326 1:CAS:528:DyaK28XhslGhsLc%3D
27. Scheltens P and Kittner B (2000) Preliminary results from an MRI/ CT-based database for vascular dementia and Alzheimer's disease. Ann NY Acad Sci 903 542-546 10818550 1:STN:280:DC%2BD3c3nvVCqsw%3D%3D
28. Selley ML (2003) Increased concentrations of homocysteine and asymmetric dimethyl arginine and decreased concentrations of nitric oxide in the plasma of patience with Alzhemier's disease. Neurobiology of Aging 24: 903-907 10.1016/S0197-4580(03)00007-1 12928048 1:CAS:528:DC%2BD3sXmsVeis7g%3D
29. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB Wilson PW and Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346: 476-483 10.1056/ NEJMoa011613 11844848 1:CAS:528:DC%2BD38XhtFCktrw%3D
30. Tarkowski E, Ringqvist A, Blennow K, Wallin A and Wennmalm A (2000) Intrathecal release of nitric oxid in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 11: 322-326 10.1159/000017261 11044777 1:CAS:528:DC%2BD3cXotlyrurk%3D
31. Vallance P, Leopne A, Calver A, Collier J and Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in renal failure. Lancet 339: 572-575 1347093 1:STN:280:By2C28jntFU%3D
32. Ventura P, Panini R, Verlato C, Scarpetta G and Salvioli G (2001) Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects. Metabolism 50 1466-1471 10.1053/meta.2001.28079 11735095 1:CAS:528:DC%2BD3MXptVGhtLk%3D